Rumi Scientific has joined with X-Chem to advance in early development a suppressor, or inhibitor, of…
Articles by Margarida Maia, PhD
People carrying fewer Huntington’s disease-causing CAG repeats in the HTT gene — who traditionally are thought to have milder…
Huntington’s disease could develop at earlier ages in people using calcium channel blockers to control hypertension, a study that…
A computer-based test called SelfCog, which tests various cognitive functions in a standardized manner, yielded promising results in assessing cognitive…
Sarah Tabrizi, MD, PhD, a researcher at the University College London (UCL) in the U.K., is the winner of this…
Subtle changes in speech are present before obvious symptoms of Huntington’s disease appear, and could potentially be a quantitative…
The Huntington’s Disease Society of America (HDSA) is awarding 56 grants totaling more than $2 million to expand its Centers of…
The first two patients in Europe have been dosed in uniQure’s Phase 1/2 clinical trial investigating AMT-130, a one-time…
The Huntington Study Group is seeking 30 patients to join KINECT-HD2, an open-label study of oral valbenazine capsules for…
NeuExcell Therapeutics has entered into a research deal with Spark Therapeutics to advance the development of a safe…